These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 7193087)
1. Nephrotoxicity of cis-diamminedichloroplatinum(II) as measured by urinary beta-glucuronidase. Kuhn JA; Argy WP; Rakowski TA; Moriarty JK; Schreiner GE; Schein PS Cancer Treat Rep; 1980; 64(10-11):1083-6. PubMed ID: 7193087 [TBL] [Abstract][Full Text] [Related]
2. [Study on urinary beta-glucuronidase and alkaline phosphatase activities as indicators of CDDP renal toxicity]. Takahashi T; Yoshida K; Nakame Y; Saitoh H Hinyokika Kiyo; 1989 Jan; 35(1):1-6. PubMed ID: 2729012 [TBL] [Abstract][Full Text] [Related]
3. [Effects of combination chemotherapy with cis-diamminedichloroplatinum (II) (CDDP) on renal function in patients with urogenital malignancies]. Kawamura J; Hida S; Higashi Y; Yamauchi T; Soeda A; Yoshida O Hinyokika Kiyo; 1985 Feb; 31(2):207-21. PubMed ID: 4040315 [TBL] [Abstract][Full Text] [Related]
4. Nephrotoxicity of cis-diamminedichloroplatinum with or without ifosfamide in cancer treatment. Hacke M; Schmoll HJ; Alt JM; Baumann K; Stolte H Clin Physiol Biochem; 1983; 1(1):17-26. PubMed ID: 6383688 [TBL] [Abstract][Full Text] [Related]
6. [Nephrotoxicity of contrast media. Comparison of iopamidol and diatrizoate by measurement of urinary enzymes after urography]. Schiavina G; Arrigo G; Vergnaghi D; Cavaliere G; Scarduelli B; Luzzatti G; D'Amico G Radiol Med; 1984 Apr; 70(4):176-9. PubMed ID: 6150520 [TBL] [Abstract][Full Text] [Related]
7. Reduction of cis-diamminedichloroplatinum nephrotoxicity in rats by optimal circadian drug timing. Levi FA; Hrushesky WJ; Blomquist CH; Lakatua DJ; Haus E; Halberg F; Kennedy BJ Cancer Res; 1982 Mar; 42(3):950-5. PubMed ID: 7199382 [TBL] [Abstract][Full Text] [Related]
8. Renal complications of cis-diamminedichloroplatinum. Nitschke R Ann Clin Lab Sci; 1981; 11(5):392-6. PubMed ID: 7199273 [TBL] [Abstract][Full Text] [Related]
9. Role of oxidative and nitrosative stress in cisplatin-induced nephrotoxicity. Chirino YI; Pedraza-Chaverri J Exp Toxicol Pathol; 2009 May; 61(3):223-42. PubMed ID: 18986801 [TBL] [Abstract][Full Text] [Related]
10. Nephrotoxicity of heptaplatin: a randomized comparison with cisplatin in advanced gastric cancer. Ahn JH; Kang YK; Kim TW; Bahng H; Chang HM; Kang WC; Kim WK; Lee JS; Park JS Cancer Chemother Pharmacol; 2002 Aug; 50(2):104-10. PubMed ID: 12172973 [TBL] [Abstract][Full Text] [Related]
11. [Determination of urinary beta-glucuronidase activity as an expression of renal damage in various forms of kidney diseases in children]. Rizzoni G; Vegni M; Bedoni D; Tomasina G Minerva Pediatr; 1970 Feb; 22(8):398-402. PubMed ID: 4911308 [No Abstract] [Full Text] [Related]
12. Renal handling of cis-diamminedichloroplatinum(II). Jacobs C; Kalman SM; Tretton M; Weiner MW Cancer Treat Rep; 1980; 64(12):1223-6. PubMed ID: 7193518 [TBL] [Abstract][Full Text] [Related]
18. [Studies on the mechanisms of renal damages induced by nephrotoxic compounds]. Yamada T Nihon Hoigaku Zasshi; 1995 Dec; 49(6):447-57. PubMed ID: 8583688 [TBL] [Abstract][Full Text] [Related]
19. Effect of para-aminobenzoic acid on the pharmacokinetics and urinary excretion of cis-diamminedichloroplatinum(II) in rats. Esposito M; Vannozzi M; Viale M; Pellecchia C; Civalleri D; Gogioso L Anticancer Res; 1995; 15(6B):2541-7. PubMed ID: 8669820 [TBL] [Abstract][Full Text] [Related]
20. Naringenin attenuates cisplatin nephrotoxicity in rats. Badary OA; Abdel-Maksoud S; Ahmed WA; Owieda GH Life Sci; 2005 Mar; 76(18):2125-35. PubMed ID: 15826879 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]